• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医学院在印度修订国家结核病控制规划(RNTCP)下对结核病控制的贡献:经验教训与未来挑战。

Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead.

机构信息

Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Indian J Med Res. 2013 Feb;137(2):283-94.

PMID:23563371
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3657851/
Abstract

Medical college faculty, who are academicians are seldom directly involved in the implementation of national public health programmes. More than a decade ago for the first time in the global history of tuberculosis (TB) control, medical colleges of India were involved in the Revised National TB Control Programme (RNTCP) of Government of India (GOI). This report documents the unique and extraordinary course of events that led to the involvement of medical colleges in the RNTCP of GOI. It also reports the contributions made by the medical colleges to TB control in India. For more than a decade, medical colleges have been providing diagnostic services (Designated Microscopy Centres), treatment [Directly Observed Treatment (DOT) Centres] referral for treatment, recording and reporting data, carrying out advocacy for RNTCP and conducting operational research relevant to RNTCP. Medical colleges are contributing to diagnosis and treatment of human immunodeficiency virus (HIV)-TB co-infection and development of laboratory infrastructure for early diagnosis of multidrug-resistant and/or extensively drug-resistant TB (M/XDR-TB) and DOTS-Plus sites for treatment of MDR-TB cases. Overall, at a national level, medical colleges have contributed to 25 per cent of TB suspects referred for diagnosis; 23 per cent of 'new smear-positives' diagnosed; 7 per cent of DOT provision within medical college; and 86 per cent treatment success rate among new smear-positive patients. As the Programme widens its scope, future challenges include sustenance of this contribution and facilitating universal access to quality TB care; greater involvement in operational research relevant to the Programme needs; and better co-ordination mechanisms between district, state, zonal and national level to encourage their involvement.

摘要

医学院的教职员工,他们是院士,很少直接参与国家公共卫生计划的实施。十多年前,在结核病(TB)控制的全球历史上,印度的医学院首次参与了印度政府的修订国家结核病控制计划(RNTCP)。本报告记录了导致医学院参与印度政府 RNTCP 的独特而非凡的事件过程。它还报告了医学院对印度结核病控制的贡献。十多年来,医学院一直提供诊断服务(指定显微镜中心)、治疗[直接观察治疗(DOT)中心]转诊治疗、记录和报告数据、倡导 RNTCP 并开展与 RNTCP 相关的业务研究。医学院正在为人类免疫缺陷病毒(HIV)-TB 合并感染的诊断和治疗做出贡献,并为早期诊断耐多药和/或广泛耐药结核(M/XDR-TB)以及 DOTS-Plus 站点治疗耐多药结核病例开发实验室基础设施。总的来说,在国家层面上,医学院贡献了 25%的疑似结核病患者转诊进行诊断;23%的新涂片阳性患者确诊;7%的在医学院提供的 DOT 服务;新涂片阳性患者的 86%治疗成功率。随着该计划扩大其范围,未来的挑战包括维持这种贡献并促进普遍获得优质结核病护理;更多地参与与该计划需求相关的业务研究;以及在地区、州、区域和国家各级之间建立更好的协调机制,以鼓励他们参与。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/c02ad7d75b15/IJMR-137-283-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/621a3a584d99/IJMR-137-283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/5e32aeb36bd9/IJMR-137-283-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/b43ecb64f8d3/IJMR-137-283-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/3a48c61aae68/IJMR-137-283-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/30e4e8a99158/IJMR-137-283-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/cd5c8fea2355/IJMR-137-283-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/a5db7a7f359f/IJMR-137-283-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/c02ad7d75b15/IJMR-137-283-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/621a3a584d99/IJMR-137-283-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/5e32aeb36bd9/IJMR-137-283-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/b43ecb64f8d3/IJMR-137-283-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/3a48c61aae68/IJMR-137-283-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/30e4e8a99158/IJMR-137-283-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/cd5c8fea2355/IJMR-137-283-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/a5db7a7f359f/IJMR-137-283-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2777/3657851/c02ad7d75b15/IJMR-137-283-g010.jpg

相似文献

1
Contribution of medical colleges to tuberculosis control in India under the Revised National Tuberculosis Control Programme (RNTCP): lessons learnt & challenges ahead.医学院在印度修订国家结核病控制规划(RNTCP)下对结核病控制的贡献:经验教训与未来挑战。
Indian J Med Res. 2013 Feb;137(2):283-94.
2
Isoniazid mono-resistant tuberculosis: Time to take it seriously.异烟肼单耐药结核病:是时候认真对待了。
Indian J Tuberc. 2019 Apr;66(2):247-252. doi: 10.1016/j.ijtb.2019.04.001. Epub 2019 Apr 9.
3
TB control in India--efforts, challenges and priorities.印度的结核病防控——努力、挑战与重点
J Indian Med Assoc. 2011 Dec;109(12):921-4, 928.
4
RNTCP 2007: looking ahead to future challenges.《印度国家结核病控制规划(RNTCP)2007:展望未来挑战》 (注:这里RNTCP如果有特定全称,需根据其实际全称准确翻译,这里只是举例一种可能,因为没有更多背景信息)
J Indian Med Assoc. 2007 Apr;105(4):192, 194, 196.
5
Clinical response of newly diagnosed HIV seropositive & seronegative pulmonary tuberculosis patients with the RNTCP Short Course regimen in Pune, India.印度浦那地区,新诊断的 HIV 血清阳性和血清阴性肺结核患者使用 RNTCP 短程方案的临床反应。
Indian J Med Res. 2011 May;133(5):521-8.
6
Performance of Revised National Tuberculosis Control Programme (RNTCP) in tribal areas in India.印度部落地区修订后的国家结核病控制规划(RNTCP)的执行情况。
Indian J Med Res. 2015 May;141(5):624-9. doi: 10.4103/0971-5916.159553.
7
First and second line drug resistance among treatment naïve pulmonary tuberculosis patients in a district under Revised National Tuberculosis Control Programme (RNTCP) in New Delhi.新德里修订后的国家结核病控制规划(RNTCP)下某地区初治肺结核患者的一线和二线药物耐药情况
J Epidemiol Glob Health. 2015 Dec;5(4):365-73. doi: 10.1016/j.jegh.2015.04.002. Epub 2015 May 2.
8
DOTS at a tertiary care center in northern India: successes, challenges and the next steps in tuberculosis control.印度北部一家三级医疗中心的直接观察短程治疗法:结核病控制的成效、挑战及后续步骤
Indian J Med Res. 2006 May;123(5):702-6.
9
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.德里地区广泛耐药结核病的发病率和危险因素。
PLoS One. 2013;8(2):e55299. doi: 10.1371/journal.pone.0055299. Epub 2013 Feb 4.
10
First- and second-line drug resistance patterns among previously treated tuberculosis patients in India.印度既往治疗结核病患者的一线和二线耐药模式。
Int J Tuberc Lung Dis. 2010 Feb;14(2):243-6.

引用本文的文献

1
Opportunistic Screening for Enhanced TB Case Detection among Inpatients in a Tertiary Care Hospital, Bengaluru.班加罗尔一家三级护理医院对住院患者进行机会性筛查以加强结核病病例发现
Indian J Community Med. 2025 Jul-Aug;50(4):636-640. doi: 10.4103/ijcm.ijcm_498_23. Epub 2025 Feb 6.
2
Pioneering an online course on research methods for India's medical postgraduates & faculty members.为印度医学研究生和教师开创一门关于研究方法的在线课程。
Indian J Med Res. 2022 Sep;156(3):384-387. doi: 10.4103/ijmr.ijmr_1077_21.
3
Nontubercular mycobacterial cough.

本文引用的文献

1
Tuberculous lymphadenopathy: a multicentre operational study of 6-month thrice weekly directly observed treatment.结核性淋巴结病:6 个月每周 3 次直接观察治疗的多中心操作性研究。
Int J Tuberc Lung Dis. 2013 Feb;17(2):234-9. doi: 10.5588/ijtld.12.0333.
2
Outcomes of Category III DOTS treatment in immunocompetent patients with tuberculosis pleural effusion.免疫功能正常的结核性胸腔积液患者中三类 DOTS 治疗的结局。
Int J Tuberc Lung Dis. 2012 Nov;16(11):1505-9. doi: 10.5588/ijtld.12.0233.
3
DOTS at a tertiary care center in northern India: successes, challenges and the next steps in tuberculosis control.
非结核分枝杆菌性咳嗽。
BMJ Case Rep. 2022 Mar 7;15(3):e246285. doi: 10.1136/bcr-2021-246285.
4
Leveraging mHealth intervention to ensure initiation of treatment for tuberculosis.利用移动健康干预措施确保结核病治疗的启动。
J Postgrad Med. 2021 Oct-Dec;67(4):194-195. doi: 10.4103/jpgm.JPGM_340_21.
5
Effect of mobile voice calls on treatment initiation among patients diagnosed with tuberculosis in a tertiary care hospital of Puducherry: A randomized controlled trial.移动语音通话对本地一家三级医院肺结核患者治疗启动的影响:一项随机对照试验。
J Postgrad Med. 2021 Oct-Dec;67(4):205-212. doi: 10.4103/jpgm.JPGM_1105_20.
6
Developing health promotional skills among medical undergraduates for tuberculosis patients: An innovative way to benefit students as well as patients.培养医学本科生针对结核病患者的健康促进技能:一种使学生和患者都受益的创新方式。
J Educ Health Promot. 2021 Mar 31;10:100. doi: 10.4103/jehp.jehp_670_20. eCollection 2021.
7
Identifying and Addressing Factors Contributing to Pretreatment Loss to Follow-Up of Tuberculosis Patients Referred for Treatment from Medical Colleges in Pondicherry: An Implementation Research.识别并解决导致本地治里市医学院转诊的结核病患者治疗前失访的因素:一项实施研究
Indian J Community Med. 2020 Jan-Mar;45(1):27-31. doi: 10.4103/ijcm.IJCM_118_19.
8
Program-Based Teaching and Learning To Increase Competency in Undergraduate Medical Students Using a Model of the Revised National Tuberculosis Control Program.基于项目的教学与学习,采用修订后的国家结核病控制项目模式提高本科医学生的能力。
J Microbiol Biol Educ. 2019 Apr 26;20(1). doi: 10.1128/jmbe.v20i1.1649. eCollection 2019.
9
Provider-initiated HIV testing & counselling in incident tuberculosis cases under National TB Programme conditions at a tertiary care teaching hospital in Tirupati, south India.在印度南部蒂鲁帕蒂的一家三级护理教学医院,在国家结核病规划条件下对新发结核病病例开展医护人员主导的 HIV 检测和咨询。
Indian J Med Res. 2017 Dec;146(6):774-779. doi: 10.4103/ijmr.IJMR_639_15.
10
Detect-Treat-Prevent-Build: Strategy for TB Elimination in India by 2025.检测-治疗-预防-建设:印度到2025年消除结核病的战略。
Indian J Community Med. 2018 Jan-Mar;43(1):1-4. doi: 10.4103/ijcm.IJCM_321_17.
印度北部一家三级医疗中心的直接观察短程治疗法:结核病控制的成效、挑战及后续步骤
Indian J Med Res. 2006 May;123(5):702-6.
4
DOTS centre at a tertiary care teaching hospital: lessons learned and future directions.一家三级护理教学医院的直接观察短程治疗中心:经验教训与未来方向
Indian J Chest Dis Allied Sci. 2004 Oct-Dec;46(4):251-6.
5
Medical schools and tuberculosis control: bridging the discordance between what is preached and what is practiced.医学院校与结核病防治:弥合说教与实践之间的脱节。
Indian J Chest Dis Allied Sci. 2004 Jan-Mar;46(1):5-7.